Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Overexpressing noggin in mice causes severe osteoporosis.

A hormone affects hair growth, certain molecules may prevent skin damage, a skin disease is linked to immune cells, glycerol helps skin hydration, and psoriasis treatment trials need improvement.

Erlotinib can cause unusual hair growth, like long eyelashes and facial hair.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

New therapies and trials are needed for Merkel cell carcinoma, a tough skin cancer.

Bevacizumab may worsen hypothyroidism, so thyroid function should be monitored during treatment.

Certain immune cells in the skin release a protein that stops hair growth by keeping hair stem cells inactive.

Cancer treatments can cause various eye problems, so eye doctors should know how to diagnose and treat these early.

Targeting androgen receptors shows promise for treating triple-negative breast cancer, but more research is needed.

Cepharanthine shows promise as a COVID-19 treatment.

CYP154C7 enzyme can effectively modify steroids and is promising for commercial use.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

Deuruxolitinib effectively improves hair regrowth in alopecia areata but requires monitoring for side effects.

Enzymes are classified into six types and are essential for many biological processes, with only a few targeted by drugs.

Vitiligo treatment is improving with new drugs and therapies, focusing on personalized and combined approaches.

New tools show that in fish, NPY increases feeding and somatostatin decreases it.

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.

In 2024, the FDA approved 27 innovative small-molecule drugs, with many offering significant treatment improvements.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

Targeting amphiregulin may improve treatment for fibrotic diseases and cancer.

The Wnt/β-catenin pathway is important for body functions and diseases, and targeting it may treat conditions like cancer, but with safety challenges.

More precise, personalized therapies are needed for autoimmune diseases.

The enzyme PA-PLA1α is important for proper hair follicle development.

EGF controls hair growth by regulating hair follicles' growth phases.

SARS-CoV-2 proteins help the virus avoid the immune system, delaying response and increasing inflammation.

Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.

Alopecia areata is caused by immune attacks on hair follicles, affecting hair growth and quality of life.

Anticancer drugs like methotrexate and trimetrexate could be effective and safe for treating malaria at low doses.

The immune processes causing VKH and vitiligo are similar in dogs and humans.